Medicor International
ActiveSummary
Medicor International has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.10M and a net result of €-23k. Equity is growing by ~16.4% per year across the filed fiscal years. Its solvency ranks better than 77% of 925 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
79
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability67▼-17
Solvency100=
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €85k at 30 days acceptable
Liquidity ample (current ratio 3.95 against 5.89 in 2024; short-term debt: 23.3% and cash: 8.6% of total assets), and 24% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 82
Relative position
BE, all sectors
reference
Sector 82
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
76%
Return on assets
-1.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
2 d early
2024
8 d early
2023
27 d early
2022
11 d early
2021
11 d early
2020
12 d early
2019
17 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-23k
2024 · €167k
2018: €87k
2019: €87k
2020: €96k
2021: €139k
2022: €101k
2023: €104k
2024: €167k
2018 → 2025
Working capital
€1.00M▲ 1.6%
2024 · €984k
2018: €309k
2019: €446k
2020: €547k
2021: €701k
2022: €691k
2023: €842k
2024: €984k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€755k-€856k▲ 13.4%€961k▲ 12.2%€1.13M▲ 17.4%€1.10M▼ 2.0%
Operating result€208k-€157k▼ 24.3%€168k▲ 6.9%€203k▲ 20.9%€97k▼ 52.5%
Net result€139k-€101k▼ 27.0%€104k▲ 3.0%€167k▲ 60.0%€-23k
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 53% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.45M
Fixed assets
€114k ▼ 20.2%
Current assets
€1.34M ▲ 13.0%
Equity and liabilities €1.45M
Equity
€1.10M ▼ 2.0%
Debt
€349k ▲ 73.5%
Debt's share of the balance-sheet total rises from 15.2% to 24.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€136k▼
2024 · €246k
Cash flow
€17k▼
2024 · €210k
Current ratio
3.95▼
2024 · 5.89
Debt to equity
0.32▲
2024 · 0.18
ROE
-2.1%▼
2024 · 14.8%
ROA
-1.6%▼
2024 · 12.5%
Interest coverage
11.75▼
2024 · 91.77
Debt ≤ 1 year
€339k▲
2024 · €201k
Income taxes
€107k▲
2024 · €82k
Staff costs
€1.12M▼
2024 · €1.23M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.33M€1.45M▲
Fixed assets21/28€143k€114k▼
Tangible fixed assets22/27€91k€62k▼
Plant, machinery and equipment23€390€39▼
Furniture and vehicles24€91k€62k▼
Other tangible fixed assets26€0€0=
Financial fixed assets28€52k€52k=
Current assets29/58€1.19M€1.34M▲
Amounts receivable within one year40/41€949k€1.22M▲
Trade receivables40€714k€1.16M▲
Other amounts receivable41€236k€60k▼
Cash at bank and in hand54/58€216k€125k▼
Deferred charges and accrued income490/1€20k€0▼
Equity and liabilities
Total equity and liabilities10/49€1.33M€1.45M▲
Equity10/15€1.13M€1.10M▼
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€6k€6k=
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Profit (loss) carried forward14€1.06M€1.04M▼
Amounts payable17/49€201k€349k▲
Amounts payable within one year42/48€201k€339k▲
Trade debts44€76k€45k▼
Suppliers440/4€76k€45k▼
Taxes, remuneration and social security45€125k€94k▼
Taxes450/3€22k€0▼
Remuneration and social security454/9€103k€94k▼
Other amounts payable47/48-€200k
Accrued charges and deferred income492/3€0€10k▲
Income statement
Code20242025
Non-recurring operating income76A€21k€75k▲
Remuneration, social security and pensions62€1.23M€1.12M▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€43k€39k▼
Other operating charges640/8€10k€87k▲
Gross operating margin9900€1.48M€1.34M▼
Operating profit (loss)9901€203k€97k▼
Financial income75/76B€48k€34▼
Recurring financial income75€7€34▲
Non-recurring financial income76B€48k€0▼
Financial charges65/66B€3k€12k▲
Recurring financial charges65€3k€12k▲
Non-recurring financial charges66B-€246
Profit (loss) for the period before taxes9903€249k€85k▼
Income taxes67/77€82k€107k▲
Profit (loss) for the period9904€167k€-23k▼
Profit (loss) for the period to be appropriated9905€167k€-23k▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.06M€1.04M▼
Profit (loss) brought forward from the previous period14P€893k€1.06M▲
Social balance
Average headcount (FTE)90875.85.0▼
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Weakest financial yearnet €-23k ▼114%
Net result drops to €-23k, the lowest in the series.
23-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2018net €167k ▲60%
Net result €167k, the highest in the series.
31-12
Financial
Equity above €1MEq €1.13M ▲17.4%
7 profitable years in a row build equity to €1.13M.
04-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
20-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
19-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
14-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Liquidity doublescurrent ratio 3.53
Current ratio from 1.72 to 3.53; short-term debt falls from €432k to €176k.
31-12
Financial
Equity above €500kEq €520k ▲20%
2 profitable years in a row build equity to €520k.
Show earlier events
08-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
24-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
28-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
15 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rotselaar · 1 establishment unit since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Wingepark 5B3110 RotselaarGround area
1.4 ha
Building footprint
773 m²
Parcel 24094C0754/00Y000, Flanders. Linked by address, not a title deed.
1 establishment unit
Medicor International
since 20112.203.330.056
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24094C0754/00Y000 | Flanders | 1.4 ha | 1 · 773 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
549300MSVKMWNUIFXZ69
Similar companies · same sector, comparable size
LL Investment
BE 0650.582.265
Middelkerke · Eq €1,100,900
Holding Fama
BE 0648.888.230
Manage · Eq €1,100,792
ABACUS
BE 0430.809.662
Hechtel-Eksel · Eq €1,096,762
KANTOOR TORRIMMO
BE 0434.401.236
Izegem · Eq €1,118,202
Lazarus
BE 0712.988.503
Brussel · Eq €1,119,503
Of 11,222 companies in sector 82100 we hold annual accounts for 3,510. 1,455 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded14-10-2011
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
82100Office administrative and support services
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.